March 10, 2017
A New York federal judge Thursday consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and rejected a motion for separate trials for cases filed by direct purchasers.
February 08, 2017
A New York federal judge on Wednesday granted the U.S. government's request to intervene in a proposed class action alleging that drugmakers conspired to substantially jack up the price of generic blood pressure medication propranolol, after the U.S. said the case could interfere with a criminal investigation.
January 05, 2017
Mylan Inc., Teva Pharmaceuticals USA Inc., Endo International PLC and nine other drugmakers conspired to substantially jack up the price of generic blood pressure medication propranolol, in violation of the Sherman Antitrust Act, a Puerto Rico-based company said in a proposed class action filed on Thursday in New York federal court.